Dc. Mcgiffin et al., PATIENT-SPECIFIC PREDICTIONS FOR CLINICAL DECISION-MAKING, Australian and New Zealand journal of surgery, 67(2-3), 1997, pp. 108-114
There are many ways in which clinicians make decisions regarding thera
py for an individual patient. Invariably, the decision is supplemented
by collateral information which is obtained from clinical trials. Pro
spective and retrospective clinical studies take an unnecessary advers
arial position but each method has its place. Parametric survival anal
ysis can product patient-specific predictions of an event of interest
for an individual patient based on the risk factor profile of that pat
ient, and these methods are just as applicable to prospective clinical
studies as they are to retrospective clinical studies. Parametric sur
vival analysis can estimate the distribution of rime to an event, esti
mate the phases of hazard (instantaneous risk of the event), determine
risk factors associated with the event in each of the identified phas
es of risk predict the time-related probability of an event fur a spec
ific patient based on his or her risk factor profile, and by risk adju
stment compare the effectiveness of different therapies.